Literature DB >> 1901950

Sequence requirements for premature transcription arrest within the first intron of the mouse c-fos gene.

N Mechti1, M Piechaczyk, J M Blanchard, P Jeanteur, B Lebleu.   

Abstract

A strong block to the elongation of nascent RNA transcripts by RNA polymerase II occurs in the 5' part of the mammalian c-fos proto-oncogene. In addition to the control of initiation, this mechanism contributes to transcriptional regulation of the gene. In vitro transcription experiments using nuclear extracts and purified transcription templates allowed us to map a unique arrest site within the mouse first intron 385 nucleotides downstream from the promoter. This position is in keeping with that estimated from nuclear run-on assays performed with short DNA probes and thus suggests that it corresponds to the actual block in vivo. Moreover, we have shown that neither the c-fos promoter nor upstream sequences are absolute requirements for an efficient transcription arrest both in vivo and in vitro. Finally, we have characterized a 103-nucleotide-long intron 1 motif comprising the arrest site and sufficient for obtaining the block in a cell-free transcription assay.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1901950      PMCID: PMC360067          DOI: 10.1128/mcb.11.5.2832-2841.1991

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  47 in total

1.  RNA polymerase II is capable of pausing and prematurely terminating transcription at a precise location in vivo and in vitro.

Authors:  O Resnekov; Y Aloni
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

2.  The Fos complex and Fos-related antigens recognize sequence elements that contain AP-1 binding sites.

Authors:  B R Franza; F J Rauscher; S F Josephs; T Curran
Journal:  Science       Date:  1988-03-04       Impact factor: 47.728

3.  Attenuation in the control of SV40 gene expression.

Authors:  N Hay; H Skolnik-David; Y Aloni
Journal:  Cell       Date:  1982-05       Impact factor: 41.582

4.  The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes.

Authors:  R Chiu; W J Boyle; J Meek; T Smeal; T Hunter; M Karin
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

5.  fos-associated cellular p39 is related to nuclear transcription factor AP-1.

Authors:  P Sassone-Corsi; W W Lamph; M Kamps; I M Verma
Journal:  Cell       Date:  1988-08-12       Impact factor: 41.582

Review 6.  Fos-associated protein p39 is the product of the jun proto-oncogene.

Authors:  F J Rauscher; D R Cohen; T Curran; T J Bos; P K Vogt; D Bohmann; R Tjian; B R Franza
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

7.  c-Jun dimerizes with itself and with c-Fos, forming complexes of different DNA binding affinities.

Authors:  T D Halazonetis; K Georgopoulos; M E Greenberg; P Leder
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

Review 8.  The regulatory strategies of c-myc and c-fos proto-oncogenes share some common mechanisms.

Authors:  J M Blanchard; M Piechaczyk; P Fort; A Bonnieu; N Mechti; J Rech; M Cuny; B Lebleu; P Jeanteur
Journal:  Biochimie       Date:  1988-07       Impact factor: 4.079

9.  Multiple mechanisms for transcriptional regulation of the myc gene family in small-cell lung cancer.

Authors:  G Krystal; M Birrer; J Way; M Nau; E Sausville; C Thompson; J Minna; J Battey
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

10.  Intragenic pausing and anti-sense transcription within the murine c-myc locus.

Authors:  A Nepveu; K B Marcu
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  34 in total

1.  Discovery of regulatory elements by a computational method for phylogenetic footprinting.

Authors:  Mathieu Blanchette; Martin Tompa
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

Review 2.  Phenobarbital induction of cytochrome P-450 gene expression.

Authors:  D J Waxman; L Azaroff
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

3.  Analysis of premature termination in c-myc during transcription by RNA polymerase II in a HeLa nuclear extract.

Authors:  L London; R G Keene; R Landick
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

4.  A DNA-binding factor in adult hematopoietic cells interacts with a pyrimidine-rich domain upstream from the human delta-globin gene.

Authors:  D O'Neill; K Bornschlegel; M Flamm; M Castle; A Bank
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

5.  Effects of heterologous downstream sequences on the activity of the HIV-1 promoter and its response to Tat.

Authors:  M E Greenberg; M B Mathews
Journal:  Nucleic Acids Res       Date:  1997-12-15       Impact factor: 16.971

6.  A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II.

Authors:  C Gongora; G Degols; L Espert; T D Hua; N Mechti
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

7.  Microarray transfection analysis of conserved genomic sequences from three immediate early genes.

Authors:  Xiaomei Ren; Michael D Uhler
Journal:  Genomics       Date:  2008-11-08       Impact factor: 5.736

8.  Stimulation of the Ca2+-mediated egr-1 and c-fos expression in murine erythroleukaemia cells by cyclosporin A.

Authors:  A Schaefer; M Magócsi; A Fandrich; H Marquardt
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

9.  A novel mouse c-fos intronic promoter that responds to CREB and AP-1 is developmentally regulated in vivo.

Authors:  Vincent Coulon; Karim Chebli; Patricia Cavelier; Jean-Marie Blanchard
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

10.  c-fos gene transcription in murine macrophages is modulated by a calcium-dependent block to elongation in intron 1.

Authors:  M A Collart; N Tourkine; D Belin; P Vassalli; P Jeanteur; J M Blanchard
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.